Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: IMNM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on IMNM, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 7,971 IMNM shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 7,971 shares
    Change vs previous 13F +153 shares

    <0.01% of the 13F portfolio, value $168,905.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 7,818 shares
    Change vs previous 13F -1,016 shares

    <0.01% of the 13F portfolio, value $170,980.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 8,834 shares
    Change vs previous 13F -2,058 shares

    <0.01% of the 13F portfolio, value $189,769.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 10,892 shares
    Change vs previous 13F +631 shares

    <0.01% of the 13F portfolio, value $127,555.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 10,261 shares
    Change vs previous 13F -3,903 shares

    <0.01% of the 13F portfolio, value $95,435.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 14,164 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $95,331.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).